Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.
To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
Issues with recruitment and retention of clinical trial participants are obvious in the numbers, 11% of sites fail to enroll a single patient and 37% under enroll, while 30% drop-out rates in clinical trials all lead to delays. The rise of niche drugs has led to more pressure to identify from smaller (albeit more strictly defined) pools of patients with rare conditions. Digital health tools are helping pharma to reach new cohorts of patients either directly or in coordination with healthcare providers. They can, for instance, enable patients to partake in trials from their homes to in theory improve recruitment and retention. However, it is still early in the demonstration that full online-only engagement modalities will dramatically increase patient enrollment into clinical trials or retain patients in clinical trials. We will discuss the strategies that have worked so far as deployed during Covid, what has been learned as we operate in this new normal and what changes are here to stay as we look to speed up the time it takes for new medications to reach patients.
Join this HealthXL Event today:
Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.
You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.
Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.
Issues with recruitment and retention of clinical trial participants are obvious in the numbers, 11% of sites fail to enroll a single patient and 37% under enroll, while 30% drop-out rates in clinical trials all lead to delays. The rise of niche drugs has led to more pressure to identify from smaller (albeit more strictly defined) pools of patients with rare conditions. Digital health tools are helping pharma to reach new cohorts of patients either directly or in coordination with healthcare providers. They can, for instance, enable patients to partake in trials from their homes to in theory improve recruitment and retention. However, it is still early in the demonstration that full online-only engagement modalities will dramatically increase patient enrollment into clinical trials or retain patients in clinical trials. We will discuss the strategies that have worked so far as deployed during Covid, what has been learned as we operate in this new normal and what changes are here to stay as we look to speed up the time it takes for new medications to reach patients.
Healthcare and Life Sciences Global Alliances at Amazon Web Services (AWS)
CEO, Biologit
Associate Director, Patient Recruitment at Alnylam Pharmaceuticals
Executive Director, Head of Digital Strategy Oncology at Bayer Pharmaceuticals
Director, Sandoz
Vice President, PRA Health Sciences
Co-founder & COO, Ancora.ai
Digital Health Platform Strategy Lead at Genentech
Administrative Director, Sober Grid
Looking to connect with digital health gamechangers beyond a meeting? Join the HealthXL Clinical Trials Optimization community to connect, learn and discuss:
Issues with recruitment and retention of clinical trial participants are obvious in the numbers, 11% of sites fail to enroll a single patient and 37% under enroll, while 30% drop-out rates in clinical trials all lead to delays. The rise of niche drugs has led to more pressure to identify from smaller (albeit more strictly defined) pools of patients with rare conditions. Digital health tools are helping pharma to reach new cohorts of patients either directly or in coordination with healthcare providers. They can, for instance, enable patients to partake in trials from their homes to in theory improve recruitment and retention. However, it is still early in the demonstration that full online-only engagement modalities will dramatically increase patient enrollment into clinical trials or retain patients in clinical trials. We will discuss the strategies that have worked so far as deployed during Covid, what has been learned as we operate in this new normal and what changes are here to stay as we look to speed up the time it takes for new medications to reach patients.
HealthXL community meetings connect senior leaders from around the world.
Our virtual Roundtables are small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.
HealthXL community members lead discussion on a defined topic among a maximum of 12 participants. There is no audience and no recordings, just an interactive space to reflect and share learnings.
At 60-minutes long, roundtables are long enough for meaningful discussion among peers, but short enough to fit into busy schedules.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
HealthXL community events give unparalleled access to digital health leaders from around the world.
Our virtual Masterclasses are 60-minute sessions where a recognised expert in their field provides an in-depth learning experience to a small audience of 8-12 members.
HealthXL Masterclasses give you a chance to join a small group of peers and ask questions of recognised experts in a private, convenient setting.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
HealthXL community events give unparalleled access to digital health experts from around the world.
Our webinars bring together panels of 3-4 global leaders from the HealthXL community to discuss core trends in digital health.
Gain insights on the latest topics in digital health and ask questions of the expert panel via chat. Webinars run for 60 minutes and recordings are shared with all attendees afterwards.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.
Be ready to lead patients into the future. Join a community of passionate leaders, innovators and gamechangers that want to advance supportive care of patients.
As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.
Our community is growing fast. Don’t miss out on your opportunity to lead the future.
Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers.
As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.
Our community is growing fast. Don’t miss out on your opportunity to lead the future.
Issues with recruitment and retention of clinical trial participants are obvious in the numbers, 11% of sites fail to enroll a single patient and 37% under enroll, while 30% drop-out rates in clinical trials all lead to delays. The rise of niche drugs has led to more pressure to identify from smaller (albeit more strictly defined) pools of patients with rare conditions. Digital health tools are helping pharma to reach new cohorts of patients either directly or in coordination with healthcare providers. They can, for instance, enable patients to partake in trials from their homes to in theory improve recruitment and retention. However, it is still early in the demonstration that full online-only engagement modalities will dramatically increase patient enrollment into clinical trials or retain patients in clinical trials. We will discuss the strategies that have worked so far as deployed during Covid, what has been learned as we operate in this new normal and what changes are here to stay as we look to speed up the time it takes for new medications to reach patients.
Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.
All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.
HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.
As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.
Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.